Glycorex Transplantation Logo

Glycorex Transplantation

🇸🇪
GTAB B
SE0000524530

Glycorex Transplantation is an innovative medical technology company based in Sweden, specializing in the development and production of immunoadsorption products. This technology enables the removal of specific antibodies for use in organ transplantation and the treatment of autoimmune diseases.

Next Quarterly Earnings

Friday, November 27, 2026
CW 48
Pre-Market
In 45 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 30, 2026

Stock Price

Frequently asked questions

When will Glycorex Transplantation report its next quarterly earnings?

Glycorex Transplantation is scheduled to report its next quarterly earnings on 11/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

How do I add the Glycorex Transplantation earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:—
Actual:—

Company Information

Name
Glycorex Transplantation
Ticker Symbol
GTAB B
ISIN
SE0000524530
Country
🇸🇪
Sweden
Sector